Javascript must be enabled to continue!
Alterations of metagenomics and metaproteomics associate kidney disease in a combination of opisthorchiasis and nonalcoholic fatty liver disease
View through CrossRef
ABSTRACT
Background
Non–alcoholic fatty liver disease (NAFLD) is prevalent worldwide and is associated with chronic kidney disease (CKD).
Opisthorchis viverrini
(Ov) infection and consumption of high- fat and high-fructose (HFF) diets exacerbate NAFLD leading to nonalcoholic steatohepatitis. Here, we aimed to investigate the effects of a combination of HFF diets and
O.viverrini
infection on kidney pathology via changes in the gut microbiome and host proteome in hamsters.
Methodology/Principal findings
Twenty animals were divided into four groups; Normal diet feeding and non-infected Ov (Normal); HFF diets feeding (HFF); Ov infection (Ov); and feeding with a combination of HFF diets and infection with Ov (HFFOv). Fecal samples were extracted and used for Illumina Miseq sequencing platform based on the V3–V4 region of the 16S rRNA gene, along with LC/MS-MS analysis. Histopathological studies and biochemical assays were also conducted. The results indicated that the HFFOv group exhibited the most severe kidney injury, as elevated KIM-1 expression and accumulation of fibrosis in kidney tissue. In comparison with the HFF group, the combined group showed higher diversity and composition. An increased number of
Ruminococaceae
,
Lachospiraceae
,
Desulfovibrionaceae
and
Akkermansiaceae
, and a lower number of
Eggerthellaceae
were observed. A total of 243 significant host proteome were identified in all groups. Analysis using STITCH predicted that host proteome associated leaky gut such as soluble CD14 and p-cresol may play a role in the development of kidney disease. Among host proteome, TGF-beta, involving in fibrogenesis, was significantly expressed in HFFOv.
Conclusions/Significance
The combination of HFF diets and
O.viverrini
infection may promote kidney injury through the alterations in the gut microbiome and host proteome. This knowledge may be an effective strategy to prevent the progression of CKD beyond the early stages.
Author summary
A diets high in fat and fructose causes nonalcoholic fatty liver disease (NAFD), which is increasing worldwide. Liver fluke (
Opisthorchis viverrini
, Ov) infection is endemic in the Mekong subregion including in the northeastern Thailand. The prevalence of opisthorchiasis caused by the infection with
O. viverrini
is associated with fatty liver and bile duct cancer. We have previously demonstrated that infection with
O. viverrini
exacerbates NAFD progression to non-alcoholic steatohepatitis (NASH) in animal models. NASH exists kidney disease severity higher than ingestion of high-fat and high-fructose (HFF) diets or infection with
O. viverrini
. Here, we further investigate whether metagenomics is more likely to change in NASH than in NAFD or opisthorchiasis conditions. The combined group had higher diversity and composition. Elevated levels of
Ruminococaceae
,
Lachospiraceae
,
Desulfovibrionaceae
and
Akkermansiaceae
and decreased levels of
Eggerthellaceae
were observed, suggesting that HFF+Ov may cause gut dysbiosis in NASH. Differentially expressed proteins were also associated with these gut microbiomes in NASH condition. In addition, we found that the association of metagenomics and metaproteomics in NASH was related to kidney disease. Analysis using STITCH predicted that host proteome may be involved in leaky gut such as soluble CD14 and p-cresol to promote kidney disease. A significantly expressed TGF-beta involving fibrogenesis was found to be associated with kidney fibrosis. Therefore, alterations of metagenomics and metaproteomics is associated with kidney disease in a combination of opisthorchiasis and nonalcoholic fatty liver disease.
Title: Alterations of metagenomics and metaproteomics associate kidney disease in a combination of opisthorchiasis and nonalcoholic fatty liver disease
Description:
ABSTRACT
Background
Non–alcoholic fatty liver disease (NAFLD) is prevalent worldwide and is associated with chronic kidney disease (CKD).
Opisthorchis viverrini
(Ov) infection and consumption of high- fat and high-fructose (HFF) diets exacerbate NAFLD leading to nonalcoholic steatohepatitis.
Here, we aimed to investigate the effects of a combination of HFF diets and
O.
viverrini
infection on kidney pathology via changes in the gut microbiome and host proteome in hamsters.
Methodology/Principal findings
Twenty animals were divided into four groups; Normal diet feeding and non-infected Ov (Normal); HFF diets feeding (HFF); Ov infection (Ov); and feeding with a combination of HFF diets and infection with Ov (HFFOv).
Fecal samples were extracted and used for Illumina Miseq sequencing platform based on the V3–V4 region of the 16S rRNA gene, along with LC/MS-MS analysis.
Histopathological studies and biochemical assays were also conducted.
The results indicated that the HFFOv group exhibited the most severe kidney injury, as elevated KIM-1 expression and accumulation of fibrosis in kidney tissue.
In comparison with the HFF group, the combined group showed higher diversity and composition.
An increased number of
Ruminococaceae
,
Lachospiraceae
,
Desulfovibrionaceae
and
Akkermansiaceae
, and a lower number of
Eggerthellaceae
were observed.
A total of 243 significant host proteome were identified in all groups.
Analysis using STITCH predicted that host proteome associated leaky gut such as soluble CD14 and p-cresol may play a role in the development of kidney disease.
Among host proteome, TGF-beta, involving in fibrogenesis, was significantly expressed in HFFOv.
Conclusions/Significance
The combination of HFF diets and
O.
viverrini
infection may promote kidney injury through the alterations in the gut microbiome and host proteome.
This knowledge may be an effective strategy to prevent the progression of CKD beyond the early stages.
Author summary
A diets high in fat and fructose causes nonalcoholic fatty liver disease (NAFD), which is increasing worldwide.
Liver fluke (
Opisthorchis viverrini
, Ov) infection is endemic in the Mekong subregion including in the northeastern Thailand.
The prevalence of opisthorchiasis caused by the infection with
O.
viverrini
is associated with fatty liver and bile duct cancer.
We have previously demonstrated that infection with
O.
viverrini
exacerbates NAFD progression to non-alcoholic steatohepatitis (NASH) in animal models.
NASH exists kidney disease severity higher than ingestion of high-fat and high-fructose (HFF) diets or infection with
O.
viverrini
.
Here, we further investigate whether metagenomics is more likely to change in NASH than in NAFD or opisthorchiasis conditions.
The combined group had higher diversity and composition.
Elevated levels of
Ruminococaceae
,
Lachospiraceae
,
Desulfovibrionaceae
and
Akkermansiaceae
and decreased levels of
Eggerthellaceae
were observed, suggesting that HFF+Ov may cause gut dysbiosis in NASH.
Differentially expressed proteins were also associated with these gut microbiomes in NASH condition.
In addition, we found that the association of metagenomics and metaproteomics in NASH was related to kidney disease.
Analysis using STITCH predicted that host proteome may be involved in leaky gut such as soluble CD14 and p-cresol to promote kidney disease.
A significantly expressed TGF-beta involving fibrogenesis was found to be associated with kidney fibrosis.
Therefore, alterations of metagenomics and metaproteomics is associated with kidney disease in a combination of opisthorchiasis and nonalcoholic fatty liver disease.
Related Results
Multi-epitope protein production and its application in the diagnosis of opisthorchiasis
Multi-epitope protein production and its application in the diagnosis of opisthorchiasis
Abstract
Background
Opisthorchiasis and cholangiocarcinoma (CCA) continue to be public health concerns in many Southeast Asian countries. Although t...
Identification of Heat shock protein family A member 5 (HSPA5) targets involved in nonalcoholic fatty liver disease
Identification of Heat shock protein family A member 5 (HSPA5) targets involved in nonalcoholic fatty liver disease
Abstract
Background
HSPA5 is an endoplasmic reticulum chaperone which regulates cell metabolism, especially lipid metabolism. There are many reports about the role of HSPA...
Grading of Fatty Liver Disease in Non-Obese Elderly Patients On Ultrasound
Grading of Fatty Liver Disease in Non-Obese Elderly Patients On Ultrasound
Background and Introduction: Non-alcoholic fatty liver disease (NAFLD) has been demonstrated that insulin resistance and metabolic syndrome are associated with non-alcoholic fatty ...
Plasma hydroxyproline, MMP‐7 and collagen I as novel predictive risk markers of hepatobiliary disease‐associated cholangiocarcinoma
Plasma hydroxyproline, MMP‐7 and collagen I as novel predictive risk markers of hepatobiliary disease‐associated cholangiocarcinoma
AbstractChronic opisthorchiasis caused by Opisthorchis viverrini infection is characterized by advanced periductal fibrosis leading to hepatobiliary diseases (HBD), including chola...
The Value of Quantitative Ultrasound Elastography in the Assessment of Non-Alcoholic Fatty Liver Disease in Children
The Value of Quantitative Ultrasound Elastography in the Assessment of Non-Alcoholic Fatty Liver Disease in Children
Objective:
This preliminary investigation aimed to assess the value of two elastography techniques, sound touch elastography (STE) and sound touch
quantification (STQ), in measurin...
Pembrolizumab and Sarcoma: A meta-analysis
Pembrolizumab and Sarcoma: A meta-analysis
Abstract
Introduction: Pembrolizumab is a monoclonal antibody that promotes antitumor immunity. This study presents a systematic review and meta-analysis of the efficacy and safety...
Complex Collision Tumors: A Systematic Review
Complex Collision Tumors: A Systematic Review
Abstract
Introduction: A collision tumor consists of two distinct neoplastic components located within the same organ, separated by stromal tissue, without histological intermixing...
Effect and Safety of Pioglitazone-Metformin Tablets in the Treatment of Newly Diagnosed Type 2 Diabetes Patients with Nonalcoholic Fatty Liver Disease in Shaanxi Province: A Randomized, Double-Blinded, Double-Simulated Multicenter Study
Effect and Safety of Pioglitazone-Metformin Tablets in the Treatment of Newly Diagnosed Type 2 Diabetes Patients with Nonalcoholic Fatty Liver Disease in Shaanxi Province: A Randomized, Double-Blinded, Double-Simulated Multicenter Study
Objective. The aim of study was to evaluate the effect and safety of pioglitazone-metformin combined treatment in the newly diagnosed type 2 diabetes patients with nonalcoholic fat...

